JPRN-UMIN000026426
Completed
未知
A Study on predictors of treatment response concerning of the efficacy of tolvaptan on refractory ascites. - Effect of tolvaptan on refractory ascites.
The third department of internal medicine, Nara Medical University0 sites30 target enrollmentMarch 7, 2017
Conditionsiver cirrhosis with refractory ascites.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- iver cirrhosis with refractory ascites.
- Sponsor
- The third department of internal medicine, Nara Medical University
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
ot available
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Adequate cardiac organ function a) Patients with conjestive heart failure above NYHA class3 b) Patients with severe hypertension 2\) Patients with severe and active infectious disease (exclude HBV,HCV hepatitis) 3\) Patients with HIV 4\) Patients taking dialysis 5\) Patients with portal tumor thrombosis (Vp3 or Vp4\) 6\) Patients with hepatic encephalopathy 7\) Patients with crutial digestive bleedings within 4 weeks 8\) Patients with the following treatment a) Systemic chemotherapy b) Being treated with invasive surgical therapy within 4 weeks 9\) Patients with oral intake difficulty 10\)Patients with severe digestive diseases 11\)Patients taking a tablet which would affect this clinical study 12\)Pregnant woman, lactating woman, or a woman suspected of pregnancy 13\)Patients with severe allergic reaction to Tolvaptan 14\)Patients with drug abuse or psychological disorders 15\) Patients concluded to be inappropriate to participate in this study by their physicians
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Prognostic and Predictive Markers of Treatment Response in Patients With PAC.Pancreatic AdenocarcinomaNCT05776342GERCOR - Multidisciplinary Oncology Cooperative Group4,050
Recruiting
Not Applicable
Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL StudyBiliary Tract CancerNCT04935853GERCOR - Multidisciplinary Oncology Cooperative Group1,350
Recruiting
Not Applicable
Investigation of predictive factors for therapeutic efficacy of immunosuppressive therapy for inflammatory bowel disease using machine learningInflammatory bowel diseaseJPRN-UMIN000046284Kyorin University300
Active, not recruiting
Not Applicable
An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal CancerColorectal CancerNCT02394834Takeda757
Completed
Not Applicable
Study on predictive factors for therapeutic effect of rTMS on major depressive disorderMajor depressive disorderJPRN-UMIN000019795Kyoto Prefectural University of Medicine20